ACADIA Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

Latest Posts

About This Stock More About This Stock
7 Monster Stock Market Predictions For The Week Of February 23
Article By: Michael J. Kramer
Sunday, February 23, 2020 12:37 PM EST
It will not be a busy week in-terms of economic news low, but we will likely see a great amount of volatility. Markets will still be trying to figure out what the potential impact of the coronavirus is on the economy.
In this article: ACAD, AAPL, AMZN, NFLX, NVDA, SPY, GOOGL
Read
False Alarm, Stocks Midday Plunge Prove To Be Just A Mild Overreaction
Article By: Michael J. Kramer
Thursday, February 20, 2020 9:27 PM EST
Markets in turmoil, the next correction is coming, the end of days are upon us.
In this article: AMD, ACAD, SPY, SPX, AMZN, BABA
Read
Stocks Rebound Sharply Filling Gaps, But Not Out Of Danger Zone
Article By: Michael J. Kramer
Tuesday, January 28, 2020 10:27 PM EST
Stocks snapped their two-day losing streak with the S&P 500 rising by over 1.2% to close around 3,280.
In this article: AMD, SPY, AAPL, SQ, ACAD, NFLX
Read
ACADIA: From Depression To Schizophrenia
Article By: MoneyShow.com
Wednesday, January 22, 2020 12:19 PM EST
At the recent JPMorgan conference, ACADIA Pharmaceuticals presented a business update highlighting several catalysts anticipated in 2020.
In this article: ACAD
Read
Stocks Continue To Climb Higher, But Is The Rally Healthy?
Article By: Michael J. Kramer
Thursday, January 9, 2020 10:16 PM EST
Stocks had another strong day. I wasn’t that thrilled with the rally.
In this article: ACAD, AAPL, IWM, BYND, JD, ROKU
Read

PARTNER HEADLINES

Latest Tweets for $ACAD

No tweets yet!

$ACAD

Sunday Trio Of Short Ideas
All Things Tech 8/28/2017 3:36:31 AM

100% agreement on $BWLD especially since it has been flat for months in a bullish market with more room to fall.

I disagree with $AMD. If AMD falls below the SMA200, absolutely short, but the Triple Bottom off 12.00 is a cause of concern + a previous ER beat + Q3 ER beat likely & sitting in oversold territory according to (MFI). $SOXX shows a Pennant as well.

$ACAD long-term is down, but short term is up. Above the SMA 20, 50 & 200.

Both AMD & ACAD is big risk little reward in my book unless the Days to Cover is a big enough window. Otherwise just not worth it in my book.

1 to 1 of 1 comments